ArriVent BioPharma (AVBP) Current Leases (2023 - 2026)
ArriVent BioPharma (AVBP) reported Current Leases of $99000.0 for Q1 2026, down 28.26% on a YoY basis from $138000.0 in Q1 2025, and up 607.14% sequentially from $14000.0 in Q4 2025.
ArriVent BioPharma (AVBP) Current Leases (2023 - 2026) Analysis & Trends
ArriVent BioPharma (AVBP) has 4 years of Current Leases data on file, last reported at $99000.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Leases fell 28.26% year-over-year to $99000.0; the trailing twelve-month figure through Mar 2026 stood at $99000.0 (down 28.26% YoY), and the FY2025 full-year result was $14000.0, down 91.36% from the prior year.
- Current Leases advanced to $99000.0 in Q1 2026, from $14000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $162000.0 in Q4 2024 to a low of $14000.0 in Q4 2025.
- A 4-year average of $116300.0 and a median of $139000.0 in 2023 frame the typical range for Current Leases.
- Across the five-year window, Current Leases climbed 15.71% in 2024 and sank 91.36% in 2025, its largest moves.
- Tracing AVBP's Current Leases over 4 years: stood at $140000.0 in 2023, then increased by 15.71% to $162000.0 in 2024, then slumped by 91.36% to $14000.0 in 2025, then surged by 607.14% to $99000.0 in 2026.
- Business Quant data shows AVBP's Current Leases at $99000.0 in Q1 2026, $14000.0 in Q4 2025, and $56000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | ArriVent BioPharma | 1.42 Bn | 1.42 Bn | - | 99,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99,000.00 |
| Dec 31, 2025 | 14,000.00 |
| Sep 30, 2025 | 56,000.00 |
| Jun 30, 2025 | 98,000.00 |
| Mar 31, 2025 | 138,000.00 |
| Dec 31, 2024 | 162,000.00 |
| Sep 30, 2024 | 157,000.00 |
| Jun 30, 2024 | 152,000.00 |
| Mar 31, 2024 | 147,000.00 |
| Dec 31, 2023 | 140,000.00 |